SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 237.57 |
| Enterprise Value ($M) | 95.44 |
| Book Value ($M) | 590.29 |
| Book Value / Share | 15.46 |
| Price / Book | 0.40 |
| NCAV ($M) | 412.86 |
| NCAV / Share | 10.81 |
| Price / NCAV | 0.58 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.23 |
| Return on Assets (ROA) | -0.21 |
| Return on Equity (ROE) | -0.25 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 12.62 |
| Current Ratio | 12.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 509.54 |
| Assets | 686.98 |
| Liabilities | 96.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 35.00 |
| Operating Income | -156.81 |
| Net Income | -134.41 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -98.18 |
| Cash from Investing | -131.15 |
| Cash from Financing | 122.24 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | BlackRock Portfolio Management LLC | 6.10 | ||
| 13G/A | Tang Capital Management Llc | 0.60 | -90.79 | |
| 13G | Biotechnology Value Fund L P | 6.40 | 84.60 | |
| 13D/A | Boxer Capital Management, LLC | 2.80 | ||
| 13G/A | EcoR1 Capital, LLC | 4.40 | -17.28 | |
| 13G/A | BlackRock, Inc. | 10.60 | 0.00 | |
| 13D/A | Boxer Capital, LLC | 8.10 | 2.48 | |
| 13D/A | Boxer Asset Management Inc. | 0.00 | ||
| 13D/A | Ra Capital Management, L.p. | 9.99 | -17.16 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 307,000 | 941,458 | 32.61 | |
| 84,575 | 702,973 | 12.03 | |
| 104,621 | 725,629 | 14.42 | |
| 49,068 | 273,330 | 17.95 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IMRX – Immuneering Corporation | IOVA – Iovance Biotherapeutics, Inc. |
| IRON – Disc Medicine, Inc. | IVVD – Invivyd, Inc. |
| IXHL – Incannex Healthcare Inc. |
Financial data and stock pages provided by
Fintel.io